Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

Recruiting now · Not applicable

Conditions studied: Hernia, Ventral, Hernia, Inguinal

In brief

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Key facts

Study ID: NCT04779918
Run by: Tela Bio Inc
People needed: 160
Starts: 2021-04-29
Expected to finish: 2029-12-30
Last updated by the study team: 2026-05-05

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subject suffers from a ventral or inguinal hernia that requires surgical repair with the use of an implant to reinforce or replace weakened or missing tissue.
The patient is scheduled for an elective robotic approach with the use of OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR.
The size of the implant needed for repair is expected to be less than or equal to 15 x 25 cm for OviTex LPR and 25 x 40 cm for OviTex Core Permanent and OviTex 1S Permanent, with no size limitation for OviTex IHR.
Subject meets CDC/SSI Wound Classification Class I (Clean), Class II (Clean-Contaminated) or Class III (Contaminated) criteria.
Subject is willing and able to sign an informed consent for the study and has signed the IRB approved Informed Consent form for this study.
Subject is able to complete Quality of Life (QoL) and pain questionnaires.
Subject is at least 21 years old.
Subject is willing to comply and able to participate fully in, and for the full duration of, the study including follow-up requirements.
Exclusion Criteria at Baseline:
Subject has a BMI of > 40
Subject meets CDC/SSI Wound Classification Class IV (Dirty-Infected) criteria
Subject is female and is pregnant or plans to become pregnant during the course of the study.
Subject has a life expectancy of < 2 years making it unlikely that the subject will successfully achieve two-year follow-up.
Subject has recent history of drug or alcohol abuse (in last 3 years).
Subject has an allergy to ovine-derived products.
Subject has participated in another clinical trial within the past 30 days or is currently involved in another clinical trial.
Subject has a strangulated hernia.
Exclusion Criteria Intraoperative:
Subject requires implant that cannot be introduced into the surgical site during the procedure via port or an existing incision.
Subject unable to receive OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR at time of surgery.

Where it is running

University of South Alabama — Mobile, Alabama, United States (enrolling)
University of Louisville — Louisville, Kentucky, United States (enrolling)
Munson Healthcare — Traverse City, Michigan, United States (enrolling)
Surgical Healing Arts Center — Fort Myers, Florida, United States
St. Luke's Hospital — Overland Park, Kansas, United States
Mohawk Valley Health System — Utica, New York, United States
Houston Methodist — Houston, Texas, United States
St. Francis Hospital — Roslyn, New York, United States
SurgOne — Denver, Colorado, United States
GenesisCare — Destin, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.